(Q40340521)

https://api.crossref.org/works/10.1172/JCI115154

19 September 2017

Reversal of daunorubicin resistance in P388/ADR cells by itraconazole (English)

1 reference

9 December 2022

0 references

1 reference

S. Gupta

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1849151

9 December 2022

J. Kim

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1849151

9 December 2022

S. Gollapudi

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1849151

9 December 2022

language of work or name

English

0 references

publication date

1 April 1991

1 reference

full work available at URL

19 September 2017

https://europepmc.org/articles/PMC295200

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1849151

https://europepmc.org/articles/PMC295200?pdf=render

9 December 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1849151

Journal of Clinical Investigation

9 December 2022

published in

1 reference

19 September 2017

87

1 reference

19 September 2017

4

1 reference

19 September 2017

1467-1469

1 reference

describes a project that uses

19 September 2017

P388/ADR

0 references

cites work

Itraconazole, a new triazole that is orally active in aspergillosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=295200

Modulation in vitro and in vivo of cytotoxicity but not cellular levels of doxorubicin by the calmodulin inhibitor trifluoperazine is dependent on the level of resistance

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=295200

Resistance to multiple chemotherapeutic agents in human cancer cells

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=295200

Mechanism of multidrug resistance

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=295200

Efficacies of four antifungal agents in experimental murine sporotrichosis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=295200

Pharmacokinetics of itraconazole following oral administration to normal volunteers

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=295200

Pharmacological modulators of DNA-interactive antitumor drugs

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=295200

P-glycoprotein: multidrug-resistance and a superfamily of membrane-associated transport proteins.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=295200

Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=295200

Cyclosporin A corrects daunorubicin resistance in Ehrlich ascites carcinoma

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=295200

Correction of altered plasma membrane potentials. A possible mechanism of cyclosporin A and verapamil reversal of pleiotropic drug resistance in neoplasia

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=295200

Treatment of mycoses with itraconazole

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=295200

Role of animal and human pharmacology in antifungal drug design

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=295200

Ketoconazole and cyclosporin

17 June 2018

1 reference

12 December 2020

First International Symposium on Itraconazole. Oaxaca, Mexico, October 7-8, 1985. Proceedings

1 reference

12 December 2020

Time course of cyclosporin/itraconazole interaction

1 reference

12 December 2020

Sterol biosynthesis inhibitors. Secondary effects and enhanced in vivo efficacy

1 reference

12 December 2020

Differential effect of the calmodulin inhibitor trifluoperazine in modulating cellular accumulation, retention and cytotoxicity of doxorubicin in progressively doxorubicin-resistant L1210 mouse leukemia cells. Lack of correlation between cellular do

1 reference

12 December 2020

Identifiers

DOI

10.1172/JCI115154

1 reference

19 September 2017

1 reference

19 September 2017

1 reference